The FCPA & Anti-Corruption for the Life Sciences Industry Conference is the preeminent FCPA compliance event for pharmaceutical, medical device, CROs and biotechnology companies. The agenda provides attendees with high-level, advanced strategies such as how to incorporate government expectations into compliance programs, minimize exposure to corruptive behavior during foreign research, and properly vet, screen and monitor third parties. Mr. Pedranti will be presenting on a panel about FCPA, corporate governance and personal liability. In this presentation, Mr. Pedranti will be discussing how to deal with audit committees, board of directors and corporate officers when FCPA issues arise.
William Pedranti’s practice is focused in business and finance with an emphasis in biopharmaceutical matters. He has extensive experience performing general company representation for both public and private companies. Mr. Pedranti has also provided counsel regarding compliance with SEC and NASDAQ corporate governance standards. He has represented acquirers and target companies in various types of mergers and acquisitions as well as other business transactions (both U.S. and international)
About Snell & Wilmer L.L.P.
Founded in 1938, Snell & Wilmer is a full-service business law firm with more than 400 attorneys practicing in nine locations throughout the western United States and in Mexico, including Orange County and Los Angeles, California; Phoenix and Tucson, Arizona; Denver, Colorado; Las Vegas and Reno, Nevada; Salt Lake City, Utah; and Los Cabos, Mexico. The firm represents clients ranging from large, publicly traded corporations to small businesses, individuals and entrepreneurs. For more information, visit www.swlaw.com.